Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-27

Clinical Trial Update: Atorvastatin Therapy on Xanthoma in Alagille Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating atorvastatin for xanthomas in Alagille syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • atorvastatin (atorvastatin)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Alagille Syndrome, Atorvastatin | Phase 4 | Status: COMPLETED